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Abstract 18 
Risks from emerging contaminants (ECs) in groundwater to human health and aquatic ecology remain 19 
difficult to quantify. The number of ECs potentially found in groundwater presents challenges for 20 
regulators and water managers regarding selection for monitoring. This study is the first systematic 21 
review of prioritisation approaches for selecting ECs that may pose a risk in groundwater. Online 22 
databases were searched for prioritisation approaches relating to ECs in the aquatic environment using 23 
standardised key word search combinations. From a total of 672, studies 33 met the eligibility criteria 24 
based primarily on the relevance to prioritising ECs in groundwater. The review revealed the lack of a 25 
groundwater specific contaminant prioritisation methodology in spite of widely recognised differences 26 
between groundwater and surface water environments in regards to pathways to receptors. The findings 27 
highlight a lack of adequate evaluation of methodologies for predicting the likelihood of an EC entering 28 
groundwater and highlights knowledge gaps regarding the occurrence and fate of ECs in this 29 
environment. The review concludes with a proposal for a prioritisation framework for ECs in 30 
groundwater monitoring which enables priority lists to be updated as new information becomes 31 
available for substances regarding usage, physico-chemical properties and hazards.  32 
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1 Introduction 39 
Research on substances of emerging concern in the aquatic environment has expanded in recent years. 40 
They are often referred to as ‘emerging contaminants’ (ECs) and as substances “that are currently not 41 
included in routine monitoring programmes” and “may be candidates for future regulation, depending 42 
on research on their ecotoxicity” and “monitoring data regarding their occurrence” in the 43 
environment.1 In some cases they are also substances which still require the development of conceptual 44 
models to describe their behaviour and occurrence in the environment.2 ECs include pharmaceuticals 45 
and personal care products (PPCP), illicit drugs, hormones and steroids, industrial substances, 46 
disinfection by-products and pesticide degradation products.2-4 Approximately 860 ECs in the 47 
environment that are currently being researched or discussed.1 There has been an increase in the 48 
monitoring of ECs in the environment, largely due to advances in analytical chemistry techniques. 49 
Contaminants can be detected in concentration ranges below 1 ng/l that were previously below the Limit 50 
of Detection (LOD).3,5 New techniques include multi-residue gas and liquid chromatography techniques 51 
coupled with mass spectrometry.3,5  52 
The potential risks from ECs to human health and aquatic ecology in the environment have been 53 
recognised,6-8 and new standards and regulations may be required.2,9-11 ECs are now understood to be 54 
“ubiquitous contaminants in the environment” and there is evidence that these contaminants can have 55 
disruptive effects to organisms at different trophic levels, including humans.12 There is also growing 56 
concerns regarding the occurrence of pharmaceuticals in the environment and the build-up of anti-57 
fungal and antibiotic resistance.13  58 
There remain many challenges for regulators and water managers regarding the monitoring of ECs in 59 
the aquatic environment.14 These challenges specifically relate to the lack of knowledge on their 60 
occurrence and fate, the number of ECs potentially present in the environment and the fact that many 61 
of them are unregulated.14,15  This is a particular concern for groundwater because the environmental 62 
fate of ECs is still not well understood.16,17 Groundwater is a valuable resource and amounts to 98% of 63 
the Earths’ freshwater18 and supplies approximately 50% of all drinking water globally.19 Drinking 64 
water treatment might only involve disinfection, meaning there is a risk of ECs contaminating supplies 65 
from groundwater.20 ECs have been detected in treated drinking water.16,20 Groundwater is also vital to 66 
the health of groundwater-dependent ecosystems such as rivers, lakes and wetlands.21  67 
1.1 Regulatory background 68 
In Europe, the Water Framework Directive (WFD) (2000/60/EC)22 requires Member States (MS) to 69 
manage water in an integrated ecosystem-based approach, and considers that all waters and their 70 
dependent ecosystems are inter-linked and inter-dependent. The key objective of the WFD is to 71 
establish good ecological status in all surface waters and good chemical and quantitative status in all 72 
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groundwaters through a formal process until 2027. The WFD does not allow for deterioration in water 73 
body status. 74 
The Groundwater Daughter Directive (GWDD) (2006/118/EC)21 further describes how the chemical 75 
status of groundwater bodies is defined using Threshold Values (TVs). They indicate environmental 76 
risk and trigger the requirement for further investigation.23 Many of the TVs relate to the protection of 77 
groundwater receptors such as rivers, groundwater-dependent terrestrial ecosystems or drinking water 78 
supplies.16,17 For many ‘classical’ contaminants there is sufficient information about the pathways and 79 
toxicity to receptors; however, not enough is known about ECs to define TVs.16  80 
A ‘chicken or egg dilemma’ prevails, as the gaps in knowledge relating to the occurrence and risk of 81 
ECs delay regulation and the lack of regulation delays the generation of monitoring data.24 The number 82 
of ECs makes it difficult to identify which ones should be monitored.25 In Europe, this has been 83 
addressed by developing a watch list for pollutants which aims “to increase the availability of 84 
monitoring data on substances posing a risk or potential risk to bodies of groundwater, and thereby 85 
facilitate the identification of substances, including emerging pollutants, for which groundwater quality 86 
standards or TVs should be set” (2014/80/EU).26 The first watch list under the Priority Substances 87 
Directive (2008/105/EC27 as amended by 2013/39/EU), has already been adopted for surface water in 88 
2015. Ten new substances including 17α-ethinylestradiol,17β-estradiol and diclofenac are listed.28  89 
A similar situation occurs elsewhere in the world for the regulation of ECs. The US Environment 90 
Protection Agency (USEPA) published a Contaminant Candidate List (CCL) for drinking water.29 This 91 
is required under the Safe Drinking Water Act (SDWA) for contaminants known or anticipated to occur 92 
in drinking waters and may require regulation in the future.29 The latest CCL (no. 4) from 2016 includes 93 
97 chemicals from industrial use, pesticides, disinfection by-products and pharmaceuticals. 94 
1.2 Emerging contaminants in groundwater 95 
Most research on ECs in the environment focuses on wastewater and surface water, while there has 96 
been less emphasis on groundwater.30 ECs have the potential to leach through subsoils to groundwater 97 
and have been detected in aquifers since the 1990s.31 ECs may get into groundwater from numerous 98 
origins as shown in Figure 1, but wastewater has been identified as the primary source.16 Point sources 99 
include private wastewater treatment systems, animal waste lagoons and landfill leachate.16 Managed 100 
artificial recharge of partially treated wastewater or surface water (i.e. bank infiltration) can also be 101 
important sources of ECs in groundwater.17 Diffuse sources include application of manure, pesticides, 102 
biosolids from sewage sludge, and atmospheric deposition.16,17,32,33  103 
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 104 
Figure 1 Sources of emerging contaminants and pathways towards receptors17 105 
 106 
Numerous studies in the USA34,35 and Europe17,30,36 provide an overview of the occurrence of ECs in 107 
groundwater. A global review of studies16 published since 1993 documented significant concentrations 108 
(102 to 104 ng/l) of ECs, which included a range of PPCPs (e.g. carbamazepine and ibuprofen), industrial 109 
compounds, and caffeine. Transformation products can be found more frequently, and in higher 110 
concentrations, than their parent compounds.4,16  111 
Previous studies have demonstrated that concentrations of ECs in surface waters are higher than those 112 
in groundwaters.7,34,35,37 In addition, the lists of ECs most frequently detected in groundwater differ from 113 
those in surface waters.7,34,35,37 For example, a comparative survey37 of 70 groundwater and 71 surface 114 
water samples in France, found that several pharmaceuticals detected in surface water were not present 115 
in groundwater. This is because the main source of ECs in the aquatic environment is wastewater 116 
effluent, which discharges directly into surface waters, while groundwater is generally less vulnerable 117 
to contaminants due to the protective properties of soils and the unsaturated zone. However, 118 
groundwater bodies in areas with an absence or only a thin layer of subsoils have increased vulnerability 119 
to contamination, including by ECs.38,39 The occurrence of ECs in UK, French and Italian groundwater, 120 
also showed higher concentrations in karstic aquifers relating to high transmissivity, and conduits.39,40 121 
In addition to infiltration through the subsurface environment, another pathway of ECs to groundwater 122 
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is via surface water-groundwater exchange.16 There remain gaps in the understanding of EC sources, 123 
the pathways to receptors and toxicity mechanisms and levels.2  124 
1.3 Prioritisation approaches for monitoring contaminants in groundwater 125 
Given the lack of knowledge about the behaviour and impacts of ECs on groundwater receptors, many 126 
ECs are not routinely monitored in groundwater.2 Both the number of ECs, and the fact that not all of 127 
them will be harmful to human health or the aquatic environment, means that prioritisation is required 128 
to develop cost effective monitoring programmes that target the highest risk ECs, which may warrant 129 
regulation in the future.2,11,14 As demonstrated by previous studies35,37, EC occurrence in groundwater 130 
can differ from surface water; in regard to the types of contaminants, detection frequencies, and 131 
concentrations. Consequently, it appears inappropriate to use priority lists developed for surface waters.  132 
Existing techniques for prioritising chemicals are generally based on the principles of risk assessment.25 133 
The risk is the probability of the occurrence of exposure of a chemical to a biological receptor multiplied 134 
by the associated effect, known as the hazard.25 The way exposure and hazard are combined to calculate 135 
the risk, varies between prioritisation approaches and this can affect the results.41 There is no standard 136 
approach for prioritising ECs in groundwater. The Common Implementation Strategy Working Group 137 
for Groundwater (CIS WGGW, 2018) has outlined a process for developing a voluntary groundwater 138 
watch list (GWWL) at an EU level.42,43 The NORMAN Network1, a group of stakeholders interested in 139 
emerging contaminants (which includes academia, industry and regulators), are also developing a 140 
prioritisation methodology for groundwater (currently unavailable). 141 
Exposure relates to the environmental occurrence of a substance, which can be estimated using simple 142 
equations or environmental fate models.40,44,45 Occurrence in groundwater is not solely dependent on 143 
source factors and the characteristics of the pathway also warrant consideration.11,16 Migration through 144 
the subsurface is determined by several factors,4,46-49 such as physico-chemical properties of the 145 
compounds as well as those of soils and subsoils. Indices have been developed for estimating the 146 
leaching potential of contaminants (mainly for pesticides).50 Existing prioritisation approaches for 147 
groundwater have used these for characterising environmental exposure. For example: the Groundwater 148 
Ubiquity Score (GUS index)51  based on the physico-chemical properties of the compounds was used 149 
to prioritise pesticides in South African groundwater52; and the Attenuation Factor (AF) also based on 150 
the physico-chemical properties, as well as soil properties, the subsurface depth and recharge53 was used 151 
for estimating the leaching quantity of sixteen ECs in Ireland54.  152 
While there are numerous studies on the prioritisation of chemicals in the aquatic environment, there is 153 
a lack of consensus on critical components, such as determining exposure in groundwater and 154 
quantifying the hazard.10,55 Only one published study2 so far had specifically set out to review 155 
prioritisation for groundwater monitoring, but neither analysed approaches in detail nor proposed any 156 
groundwater specific techniques. Consequently, there is a need to review prioritisation techniques to 157 
 Page 5 
determine the best approach for prioritising ECs in groundwater. This will help to focus groundwater 158 
monitoring efforts on those ECs that present the highest risk to human health or ecological receptors. 159 
To the authors knowledge this paper provides the first critical review of prioritisation approaches for 160 
selecting ECs for monitoring that may pose a risk in groundwater. It reviews existing approaches to 161 
provide a synthesis of their elements which may be appropriate for groundwater and to identify 162 
knowledge gaps. The specific objectives of the review are to: 1) review existing prioritisation 163 
approaches for ECs with an emphasis on methodologies that can be used for groundwater; 2) evaluate 164 
the methodologies within these prioritisation approaches for predicting EC occurrence in groundwater; 165 
3) analyse the prioritisation results from a subset of studies to examine similarities and differences, and 166 
the impact of an approach on the result; and 4) describe a framework for a prioritisation approach for 167 
ECs in groundwater and make recommendations for further research. 168 
2 Systematic review criteria 169 
The systematic review was conducted following the general principles published in “The Production of 170 
Quick Scoping Reviews and Rapid Evidence Assessments”.56 A predefined protocol was developed by 171 
the authors and extracts are available in Supplementary Information A. The keywords searched are 172 
outlined Supplementary Information A, the record of results returned is in Supplementary Information 173 
B. The search source of published literature was the online database Scopus. Some of the recent work 174 
in this field has not been published within peer-reviewed journals, therefore, websites of relevant 175 
specialist organisations such as USEPA and EU Joint Research Council (JRC) were also searched.  176 
Following the screening of titles and abstracts, the remaining articles were examined in full to determine 177 
their eligibility for inclusion in further assessment. This selection generated a more focused group of 178 
studies to improve quality and the confidence of the analysis relating to the research question. A 179 
predefined scoring system for relevance and quality was developed as part of the protocol 180 
(Supplementary Information A). Studies were included if they had a relevant outcome (i.e. a prioritised 181 
list of chemicals for water quality monitoring purposes) and were of sufficient quality. The quality was 182 
determined through a process of critical appraisal to ensure only reliable studies were included. For 183 
example, criteria included the study having a clear aim and transparent methodology. For the eligible 184 
studies, key information on the prioritisation approaches was extracted (see Supplementary 185 
Information A). 186 
3 Prioritisation approaches for monitoring ECs in groundwater  187 
3.1 Study characteristics from systematic review 188 
A total of 672 studies were identified and following the screening and eligibility assessment 33 studies 189 
were deemed eligible for inclusion in the review. The primary reason for exclusion was the lack of a 190 
relevant outcome, that is, the study did not include a prioritised list of chemicals for water quality 191 
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monitoring purposes. Summary results from this systematic review of published prioritisation studies 192 
are shown in Figure 2 (see Supplementary Information C (Table D) for details of the study 193 
characteristics). All studies were available in the English language and dated from 2003 to 2016. Many 194 
were published since 2014, accounting for 50 % of the studies included. 195 
 196 
Figure 2. Summary results from review of studies of prioritisation approaches for ECs, a) key 197 
contaminant groups included in published prioritisation approaches, b) range of environmental 198 
media, c) geographical coverage of studies, d) types of approaches for prioritisation. SW=surface 199 
water, GW=groundwater, DW=drinking water. Ph=human pharmaceuticals, Pv=veterinary 200 
pharmaceuticals, Legacy=regulated legacy contaminants, Pest=pesticides, OM=organic micro-201 
pollutants, PCP=personal care products, EDC=endocrine disrupting compounds, 202 
DBP=disinfection by-products. 203 
Only a very small proportion of published prioritisation studies were found to have a groundwater focus 204 
(Figure 2a). The majority of the studies were aimed at surface water (n = 21). A total of nine studies 205 
related to groundwater, with only two focused on groundwater (see Supplementary Information C 206 
(Table E) for full table of results). Five studies were aimed at both surface water and groundwater, and 207 
a further two for surface water, groundwater and drinking water. 208 
Eight of the studies focused on ECs as a general category, with a further three examining legacy 209 
contaminants and ECs together (Figure 2b). Two studies were aimed specifically at organic micro-210 
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pollutants, three related to pesticides and one to disinfection by-products. Half of the studies (n = 17) 211 
focused on pharmaceuticals in the environment. Ten of these studies were for human pharmaceuticals, 212 
five for veterinary and two for both. Two of the studies focusing on pharmaceuticals also included 213 
personal care products.  214 
The selected studies were conducted in 13 different countries or regions (Figure 2c). Most of the studies 215 
were undertaken in European countries (n = 21), six at a European scale and four based in the UK. The 216 
USA also accounted for a significant number of the studies (n = 7).  Five studies were from other 217 
countries (Korea, China, South Africa, Iraq and Lebanon).  218 
The examined studies represent several different approaches of combining exposure and hazard 219 
assessments to determine risk, including the risk ratio approach, and scoring systems or matrices (Figure 220 
2d). Seventeen studies followed the risk ratio approach which was used slightly more frequently than 221 
the scoring system approach. The risk ratio approach relies on having the dose-response toxicological 222 
data for the relevant trophic levels and receptors but is considered a simple to use method and it is easy 223 
to communicate the results.57 A value above one indicates risk and may activate the substance's inclusion 224 
in monitoring programmes.10,44,58 The scoring approaches involved categorising and combining scores 225 
for exposure and hazard. For example, for exposure leaching indicators can be used and for hazards, 226 
classification data can be used instead of dose-response data. There were 15 scoring system approaches, 227 
three of which also used a matrix approach for combining the scores. Six of the studies used a 228 
combination of the risk ratio and scoring system approach. Examples were the EU WFD prioritisation 229 
studies58-60, where their first stage screening involved scoring chemicals based on the persistence, 230 
bioaccumulation and toxicity (PBT) approach and then the second stage prioritisation was based on the 231 
risk ratio approach.  232 
Only a very small proportion of published studies were found to have a groundwater focus and of those 233 
only one covered ECs specifically (Figure 2). This highlights the limited attention that has been paid to 234 
groundwater and groundwater receptors to date. The number of substances and groups of substances 235 
covered so far for both surface water and groundwater is also very limited, and the geographical 236 
coverage biased to Europe and USA. This emphasises the need for prioritisation approaches to now 237 
look beyond traditional hotspots of surface water and wastewater systems and consider approaches that 238 
are appropriate for the protection of groundwater bodies. A wider geographical scope is needed, and 239 
risk to groundwater from ECs may be region or country specific in terms of substances used, quantities 240 
used, as well as pathways for potential groundwater contamination. The tendency for prioritisation of 241 
pharmaceuticals, could lead to some other ECs escaping scrutiny.54 This may be referred to the 242 
“Matthew effect” whereby “the prominence of a few contaminants targeted for investigation is dictated 243 
largely by the attention devoted to them in the past”. 54 Some of the prioritisation studies10,57,61 which 244 
examined ECs and some classical contaminants had only included few pharmaceuticals in their priority 245 
lists. 246 
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3.2 Limitations of the study 247 
This review has several limitations including a risk of bias in the results because there were repetitions 248 
in the prioritisation approaches included. About half of the studies only updated existing approaches or 249 
applied them, and sometimes the same authors were involved in more than one study. This can result 250 
in showing trends in the approaches used, just because they have been used previously. The same is 251 
also true for the types of ECs studied due to the focus on pharmaceuticals. It was beyond the scope of 252 
this review to consider unpublished prioritisation approaches and therefore other approaches for 253 
prioritisation of ECs in groundwater may be applied in some countries that were not included. As 254 
discussed in Section 6 there were limitations with comparing the results of different prioritisation 255 
approaches and these should be addressed in future to help verify the results. 256 
4 Approaches for assessment of environmental exposure of ECs in groundwater  257 
This section describes the trends in the methods for exposure assessment, their applicability to the 258 
groundwater environment and highlights the strengths and weaknesses. Table 1 provides an overview 259 
of the characteristics of the exposure (and hazard) assessment in each of the studies. 260 
 Page 9 
Table 1 Summary approach to exposure and hazard assessment 261 
 Exposure Hazard 
 Generic Surface water Groundwater Receptors Dose response Classification 
Reference 
C
h
em
ic
a
l 
P
ro
p
er
ty
 
S
a
le
s 
U
sa
g
e
 
M
et
a
b
o
li
sm
 
P
re
d
ic
t 
co
n
c 
S
W
 
M
ea
su
re
d
 c
o
n
c 
S
W
 
P
re
d
ic
t 
co
n
c 
G
W
 
M
ea
su
re
 c
o
n
c 
G
W
 
L
ea
ch
in
g
 I
n
d
ic
a
to
rs
 
E
co
lo
g
y
 
H
u
m
a
n
 
A
lg
a
e
 
D
a
p
h
n
ia
 
F
is
h
 
M
a
m
m
a
li
a
n
 
H
u
m
a
n
 d
o
se
  
P
er
si
st
en
ce
 
B
io
a
cc
u
m
u
la
ti
o
n
 
C
a
rc
in
o
g
en
ic
it
y
 
M
u
ta
g
en
ic
it
y
 
T
er
a
to
g
en
ic
it
y
 
E
n
d
o
cr
in
e 
d
is
r
u
p
ti
o
n
 
N
eu
ro
to
x
ic
it
y
 
Boxall et al. 62   ● ●      ●  ● ● ●          
Capleton et al. 63  ●  ●       ●     ●  ● ● ● ● ● ● 
Besse and Garric64   ●  ● ●     ●  ● ● ●  ●  ●      
Kim et al.65  ●  ●      ● ●     ●        
Kools et al.66 ●    ●     ●      ●        
USEPA29,67  ● ●   ●  ●   ●     ●   ● ● ●   
Götz et al.25 ● ●    ●                  
Hebert et al. 68      ●  ●   ●        ● ●    
Kumar and 
Xagoraraki69 
     ●    ● ● ● ● ●    ● ● ● ● ● ● 
Murray et al.70      ●  ●   ●     ●        
Daginnus et al.59 
(WFD) 
● ●   ●     ● ● ● ● ●   ● ● ● ● ●   
Diamond et al.57       ●    ●  ● ● ●   ● ●    ●  
von der Ohe et al.10      ●    ●  ● ● ●          
Coutu et al.71          ● ●     ●  ● ● ●    
Sui et al.11  ●   ●     ●  ● ● ●    ●      
Ortiz de García et al.72      ●    ●  ● ● ●   ● ●      
Bouissou- Schurtz et 
al.73 
●    ● ●    ●  ● ● ●          
Dabrowski et al.52 ● ● ●      ●  ●        ● ● ● ● ● 
LaLone et al.74          ●    ●          
Maruya et al.75     ● ●    ●    ●          
Carvalho et al.(JRC)58 ● ●   ●     ● ● ● ● ●  ●        
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 Exposure Hazard 
 Generic Surface water Groundwater Receptors Dose response Classification 
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(WFD) 
Chirico et al.(JRC)60 
(WFD) 
● ●   ●     ● ● ● ● ●   ● ● ● ● ● ●  
Di Nica et al.76 ●  ●  ●     ●  ● ● ●          
Ki et al.50 ●  ●      ●               
Kuzmanović et al.77      ●    ●  ● ● ●          
Al-Khazrajy and 
Boxall78 
  ●  ●     ● ● ● ● ●  ●        
Busch et al.79      ●    ●  ● ● ●          
CIS WGGW43 ●       ● ● ● ● ● ● ●   ● ● ● ● ● ●  
Clarke et al.54 ●    ●  ●    ●   ●          
Donnachie et al.61      ●    ●  ● ● ●          
Guo et al.80  ●   ●     ● ● ● ● ● ● ●        
Mansour et al.81  ●   ●     ● ● ● ● ● ●  ● ●      
Sangion and 
Gramatica82 
         ●  ● ● ●          
Notes: a. Exposure assessment not included as part of this study. b. Hazard assessment not included as part of this study. Conc = concentration; SW = surface 262 
water; GW = groundwater.  263 
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The application of Measured Environmental Concentration (MECs) as a measure of environmental 264 
exposure was found to be a common approach (n = 17). MEC values from surface water were utilised 265 
in 13 of the included studies and four studies applied MEC values from groundwater. The use of MECs 266 
for groundwater are discussed further in Section 4.1. 267 
Calculating Predicted Environmental Concentrations (PEC) was also a common approach with a total 268 
14 studies using this approach to characterise exposure. Only one study calculated PECs specifically 269 
for groundwater. Sales or usage data was frequently used to estimate PECs (11 studies). It can be 270 
difficult to obtain the data required on sales, usage and environmental releases of ECs relevant to 271 
groundwater exposure. For example, it would be an enormous task to obtain usage data for all 272 
pharmaceutical compounds in the UK, and this type of information is not currently systematically 273 
reported or acessable.80 Two studies did not use sales or usage data to calculate the PEC: one study75 274 
used wastewater effluent data to calculate PECs in surface water and the other study66 on veterinary 275 
pharmaceuticals used estimates of the number of animals.  276 
Five of the studies that calculated the PEC in surface water were for human pharmaceuticals using the 277 
European Medical Agency (EMA) guidelines83. Two of the studies calculated the PEC in surface water 278 
for veterinary pharmaceuticals using another EMA guideline84. The PEC in surface water was 279 
calculated using a European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) 280 
Targeted Risk Assessment (TRA) Tool by the three WFD studies58-60, the first in 201159 and then in 281 
201558,60. The latter also applied the FOCUS model in addition to the PEC calculation of 282 
pharmaceuticals in wastewater.58,60 PECs were therefore calculated mostly for surface waters using 283 
established methods for specific contaminant groups such as human or veterinary pharmaceuticals, or 284 
pesticides. In addition, none of these studies used MECs to validate the PECs. Only one study73 285 
compared PEC and MECs and found a poor relationship which they did not scrutinise. 286 
Five studies used neither MEC or PEC for characterisation of exposure in the water environment. Three 287 
of the studies62-64, used sales or usage data as an indicator of exposure in surface water. Each of the 288 
studies were for veterinary pharmaceuticals and all involved the same author which may bias the results. 289 
Overall only four studies43,50,52,54 predicted concentrations in groundwater or the likelihood of a 290 
contaminant entering groundwater (see Supplementary Information C). Two studies used neither the 291 
MEC or PEC approach and instead used leaching indicators: one study used the extended Attenuation 292 
Factor (AF)50 and another used the Groundwater Ubiquity Score (GUS index)52. The Groundwater 293 
Watch List (GWWL) study41 proposed a leaching indicator scoring system based on chemical properties 294 
and also incorporated MECs of ECs where they are available. The fourth study54 used a model which 295 
incorporated the AF and an application rate for biosolids to calculate PEC. Two of the studies focused 296 
on pesticides50,52 and two studies43,54 covered ECs; one of which considered only one source (spreading 297 
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of biosolids)54 and the second4342 considered all ECs but this methodology has yet to be implemented at 298 
the EU level and will be done on a voluntary basis. 299 
The review highlighted that there is no trend in the methodologies for predicting concentrations of ECs 300 
in groundwater or the likelihood of a contaminant entering groundwater. Therefore, rationales and the 301 
limitations of these methodologies have been examined in further detail in Sections 4.1 and 4.2. 302 
4.1 Measured Environmental Concentrations (MEC) 303 
The application of MECs as a measure of environmental exposure has been demonstrated as a common 304 
approach. It is a reliable representation of environmental exposure because the results represent actual 305 
occurrence rather than estimates. However, there is a dependency on availability of monitoring data 306 
which there may be a lack of for ECs. The EU WFD surface water prioritisation studies58-60 used 307 
monitoring data where possible and modelling was undertaken for substances where an insufficient 308 
quantity of monitoring data was available.58 The USEPA29,67 similarly used environmental release data 309 
and production data in the absence of MECs. 310 
There are further considerations when the MEC approach is used, which include how to summarise the 311 
data to be representative of the risk, and dealing with results below the LOD. Studies that used MECs 312 
commonly incorporated both the frequency of detection of a compound, as well as the magnitude of its 313 
concentration. Frequency addresses regularity of occurrence and the magnitude addresses intensity. 314 
Concentrations could change over time which is difficult to capture57 with the paucity of monitoring 315 
data of ECs in groundwater in particular. The magnitude can be represented by the mean concentration, 316 
the maximum or both.29,43,67 Most studies opted for the conservative approach of using the maximum 317 
concentration (e.g. 10,70,73,77). One study10 calculated the 95-percentile concentration of the sites to help 318 
account for spatial variations. Only a few studies reported whether the MECs were influenced by 319 
sources such as wastewater treatment plants.   320 
The studies differed in their approaches to dealing with values below the LOD. Several studies10,29,67 321 
truncated the dataset by excluding data below the LOD. Alternatively, one study71 left censored data by 322 
replacement with the highest LOD value to take a more conservative approach. Caution should be taken 323 
when dealing with MEC datasets with a high proportion of censored results, (i.e. < LOD) and 324 
substitution methods, such as replacing non-detects with half the detection limit or zero, are not 325 
recommended for calculation summary statistics (mean, median, quartiles). Statistical approaches such 326 
as Maximum Likelihood Estimation (MLE) and Regression on Order Statistics (ROS) should be used 327 
for estimating summary statistics.84 328 
It can be argued that excluding less than values is appropriate in the context of prioritisation, because 329 
highly toxic chemicals that are frequently monitored but not often detected would result in a high risk, 330 
when in fact any risk is more likely to be low.10 Conversely, disregarding MECs below the LOD could 331 
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possibly lead to an underestimation of the real risk if the ECs are hazardous but present at low levels 332 
that could still be harmful to human health or the environment.  333 
4.2 Exposure assessments for the likelihood of a contaminant to enter groundwater 334 
4.2.1 Physico-chemical properties of ECs 335 
The likelihood of a contaminant entering groundwater is considered higher if the contaminants’ sorption 336 
coefficient is low (indicating higher mobility) and persistence is high,86 where persistence is defined as 337 
the long-term exposure to an organism and is based on the half-life data. 87 Two studies41,52 focussed on 338 
physico-chemical properties of ECs in their prioritisation.  339 
The GWWL methodology43 used a simple scoring system to indicate the likelihood of an EC reaching 340 
groundwater. The REACH guidelines87 provide indicators for persistent chemicals based on the half-341 
life in water >40 days (P) and >120 days indicating very persistent (vP) chemicals. The GWWL scoring 342 
methodology for persistence was consistent with this and the Pesticide Properties Database (PPDB).86 343 
The GWWL methodology43 proposed two indicators for mobility: logKoc and logKow. Koc is the ratio of 344 
the concentration of the contaminant that is sorbed to the organic carbon in the soil versus that which is 345 
in solution.88 The Kow relates to the equilibrium partitioning of a contaminant between octanol and water 346 
phases and is a surrogate for Koc.88 The GWWL methodology43 gave higher risk scores for contaminants 347 
less likely to sorb to the soil and therefore more likely to reach groundwater. While this criterion is 348 
reasonable, the actual thresholds for the scoring in the methodology were neither explained nor justified.  349 
The second study52 to focus on physico-chemical properties of ECs utilised the GUS index as an 350 
indicator of environmental exposure to prioritise pesticides in South African groundwater. The GUS 351 
index applies the Koc and the half-life in soil52 and is widely used as an indicator of pesticide 352 
mobility52,89. They scored the pesticides with a GUS index of greater than 2.8 as highly mobile and 353 
those with a value of less than 1.8 as non-leachers. Again, this is consistent with the REACH 354 
guidelines87 and the PPDB86. 355 
Using EC physico-chemical properties has merits as a screening tool for determining the likelihood of 356 
an EC entering groundwater relative to other substances. However, there are also some obvious 357 
drawbacks and uncertainties. It is difficult to predict the half-life and mobility of chemicals in 358 
environmental field conditions, and they are dependent on variables including temperature, pH, 359 
moisture, microbial populations and the soil type.86,90,91 Many authors92,93  have illustrated that chemicals 360 
can be neutral or ionic depending on the soil pH and therefore their sorption capacity changes, and as a 361 
result logKow may not the be most universally appropriate indicator.94 Therefore, these methods are 362 
more appropriate for non-polar organic chemicals, such as pesticides, where they contribute to a better 363 
understanding of environmental fate and transport dynamics.95 However they may not be appropriate 364 
for non-polar ECs such as pharmaceuticals. Other studies have demonstrated a relationship between the 365 
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frequency of detection of pesticides and the GUS index, but also revealed that some presumed non-366 
leaching pesticides were actually detected in groundwater.91 367 
Neither study tested the sensitivity of their results for these leachability indicators. Also, the results 368 
were not verified by comparing the higher risk ECs with environmental data. These findings highlight 369 
that approaches that only use physico-chemical properties of ECs as leachability indicators can 370 
potentially mask or overestimate risks.  371 
4.2.2 Pathway to groundwater  372 
The vulnerability of groundwater to ECs is also dependent on many other factors including the physico-373 
chemical properties of the soil and subsoil, the depth to groundwater and the recharge rate. The AF 374 
(attenuation factor) is a simple index for ranking the leaching potential of pesticides and has been 375 
frequently used in the past (e.g. 95-97). It was proposed in 198553 and is based on the half-life of the 376 
pesticide, depth of the soil, bulk density, organic carbon, sorption coefficient and recharge rate.  377 
The extended AF was utilised in one study50 as part of a geospatial leaching tool for agrochemicals in 378 
the USA. It accounted for the properties of Volatile Organic Compounds (VOCs) as well as pesticides, 379 
by adding in the dimensionless Henry's constant (Kh) (air partition coefficient) and the diffusion 380 
coefficient in soil. They used digital mapping of annual pesticide usage, soil properties and recharge to 381 
examine the variation in potential leaching loads over a regional scale, and found it could distinguish 382 
between areas of high and low susceptibility.  383 
The second study54 to apply the AF adapted a model for estimating PECs of pesticides in groundwater 384 
for sixteen organic ECs detected in biosolids in Ireland. It calculated the leaching quantity as a function 385 
of the AF and the application rate, the fraction intercepted by the crop and the thickness of the 386 
unsaturated zone.  387 
Neither study attempted to verify their methods by comparing results with actual groundwater 388 
monitoring data. However, both studies50,54 did undertake a sensitivity analysis on the parameters and 389 
found that Koc and soil organic carbon were the most sensitive.  In research into uncertainty analysis on 390 
the AF method it was found that a small variation in the retardation factor (i.e. retention in the mobile 391 
phase) could lead to different prioritisation classifications98. The authors of the study using the 392 
geospatial leaching tool50 did acknowledge issues with the spatial and temporal map resolution. They 393 
emphasised the trade-off between the data availability and the accuracy of the predictions and concluded 394 
that their tool should only be used as a first step rapid and large-scale tool.50 Approaches that incorporate 395 
geographical information at a regional scale are now common practice (e.g. 99-103). Soil and groundwater 396 
models are considered to be less appropriate for generic risk assessments for determining monitoring 397 
programmes, as they can be too site specific.44 398 
A better understanding of the fate and transport of ECs in groundwater is required to inform risk 399 
assessments, particularly their sorption and degradation.16,104 In recent years, there have been several 400 
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studies on the leaching potential of certain ECs, predominantly pharmaceuticals. For example, one 401 
research study104 examined the irrigation of soil columns and irrigated fields to assess the leaching 402 
potential of acidic pharmaceuticals (ibuprofen, gemfibrozil, naproxen, ketoprofen, and diclofenac). At 403 
higher pH values (>8) these compounds tended to take their ionised more soluble state which increased 404 
their leaching abilities. However, no contamination of these pharmaceuticals in groundwater was 405 
observed.104 Another study105 found differing sorption of PPCPs with triclosan and octylphenol being 406 
moderately to strongly sorbed and negligible for carbamazepine. These authors demonstrated that 407 
microbial activity and soil organic carbon were important for the degradation. The relative persistence 408 
(28 to 39 days in unsterilized soils) and poor sorption of carbamazepine indicated that it is more likely 409 
to leach to groundwater.105 Other studies have also highlighted carbamazepine as being relatively 410 
persistent and being prone to accumulate in soil.104,106,107 Detections of carbamazepine have been 411 
observed in groundwater possibly as a result of the long-time available for downward migration due to 412 
its high persistence.104 Consequently there are many factors that may determine the presence of ECs in 413 
groundwater and research into their persistence and sorption capabilities in environmental conditions is 414 
still on-going. In addition, the lag time between environmental releases and the potential occurrence in 415 
groundwater needs to be considered when attempting to verify prioritisation approaches.   416 
4.3 Outlook for exposure assessments for the likelihood of an EC entering groundwater  417 
The review found that the use of MECs is the preferred method for surface water and groundwater and 418 
more reliable more for representing environmental exposure especially for groundwaters where it is 419 
difficult to estimate the concentrations. Careful consideration is required when summarising data and 420 
dealing with results below the LOD so that the data is representative of the risk of exposure. Data should 421 
be summarised using statistically sound methods that are appropriate for the particular MEC dataset. 422 
However, there is still insufficient monitoring data for most ECs and therefore estimates will still be 423 
required.42 It is important therefore to generate a comprehensive list of ECs that have the potential to 424 
occur in groundwater that may not yet be measured. This initial list could be vast and therefore should 425 
be drawn up with the involvement of stakeholders.59 There is still a dependence on the availability of 426 
sales and usage data and data on the physico-chemical properties of ECs which is not as accessible as 427 
other contaminant groups that are regulated such as pesticides.42 428 
Unlike for surface water there are no standard methods for calculating PECs for ECs in groundwater. 429 
Only four studies were found to estimate the likelihood of an EC reaching groundwater or calculate 430 
PECs which all used slightly different approaches. Approaches that only use physico-chemical 431 
properties of ECs as leachability indicators can potentially mask or overestimate risks. Nevertheless, it 432 
should be acknowledged that these simple approaches can be useful as first steps in the development of 433 
monitoring programmes.52 However, from the studies reviewed it is not clear that they are treated as 434 
such, due to the lack of sensitivity testing of results, verification with monitoring data or other 435 
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prioritisation studies and no mechanisms to update the methods with new data and understanding as 436 
they become available.  437 
Depending on physico-chemical properties of the EC does not reflect real environmental 438 
conditions.84,90,91 In theory the two studies which incorporate the vulnerability of groundwater to 439 
contamination from ECs should provide a more accurate representation of the risk of exposure. 440 
However, similar to the approaches that use only physico-chemical properties of ECs, these methods 441 
that incorporate the pathway still do not verify the prioritised results with monitoring data. There is an 442 
inherent difficulty in doing this because the fate and transport of ECs may vary in different 443 
environmental conditions and there is also a lag time to consider for groundwater due to varying 444 
contaminant velocities through in the unsaturated zone. Also, care needs to be taken in the application 445 
of tools developed for certain organic contaminants to other ECs, such as acidic pharmaceuticals which 446 
may have very different mobility. Therefore, it is not possible to determine a completely unified 447 
approach for determining exposure of ECs in groundwater but it is clear that there is a requirement to 448 
incorporate new data and research on the sorption and degradation of ECs into any prioritisation 449 
approach to improve predictions of exposure.  450 
5 Approaches for hazard assessment of ECs in groundwater 451 
This section provides a review of the methods used to characterise the hazard in each of the studies 452 
included (Table 1). Twenty-five of the studies dealt with aquatic ecology as the receptor and sixteen for 453 
human health. The approaches for assessing the hazard were grouped into two different types: firstly 454 
those that used dose-response data and secondly classification data used in the scoring system approach.  455 
5.1 Dose-response data hazard assessments 456 
Of the studies that used dose-response data (n = 29), 20 used ecotoxicological data for three trophic 457 
levels. Only two studies used mammalian toxicology data. Most of the studies reported using 458 
experimental data from existing databases and literature and eight studies reported using Quantitative-459 
Structure-Activity-Relationship (QSAR) data, which estimate the effects based on structural properties 460 
of chemical compounds.108  461 
Studies using dose-response data typically considered three trophic levels of aquatic ecology. Ten 462 
studies used human dosage information as indicators of toxicity in humans, applying either the 463 
Acceptable Daily Dose (ADI) (n = 6) as “a measure of the amount of a specific substance in drinking 464 
water that can be ingested daily over a lifetime without an appreciable health risk”109 or Therapeutic 465 
Dose TD (n = 4) as the amount required to have the desired therapeutic effect. Only one study66, applied 466 
the therapeutic dose as a surrogate for toxicity data for aquatic ecology.  467 
For the nine studies that incorporated groundwater, six used dose-response data. Human health was the 468 
main receptor considered in these studies (n = 7) and only two considered aquatic ecology. The 469 
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bioavailability of an EC was generally not accounted for in these approaches, with the exception of one 470 
study10 in this review which corrected the MEC for bioavailability. The lack of experimental 471 
ecotoxicological data is considered the norm rather than the exception for many compounds.10,59 Recent 472 
studies have highlighted that ECs require further toxicological data to be developed.10,55  473 
Several authors10,64,72 emphasised that chronic toxicology data sets are the most appropriate to use for 474 
hazard assessments of ECs because the main concern relates to long-term exposure at relatively low 475 
concentrations. Availability of data for chronic exposure remains low and therefore a reliance on acute 476 
data was also highlighted by the same authors.10,64,61 A conservative approach proposed was to use the 477 
lowest available PNEC, even if it is an acute endpoint.10 Certain health effects cannot be predicted using 478 
acute or chronic dose-response tests.10 In one study57, different toxicological endpoints for ECs known 479 
to have estrogenic activity were used instead. This was the only study where this approach was 480 
undertaken, but few details were provided.  481 
5.2 Classification data hazard assessments 482 
Eleven studies used classification data to characterise the hazard. Only two of these studies did not use 483 
any dose-repose toxicity data in addition to the classification data. A number of studies incorporated 484 
specific long-term health effects data for carcinogenicity (n = 9), mutagenicity (n = 9), teratogenicity 485 
(n = 7), endocrine disruption (n = 6) and neurotoxicity (n = 3). Several studies also used persistence (n 486 
= 6) and bioaccumulation (n = 11) properties of the EC for prioritising the hazard.  487 
Due the focus on human health in groundwater studies (7 of the 9 studies), the long-term health effects 488 
classification approach was used in five of the studies. Only two studies that incorporated groundwater 489 
used persistence or bioaccumulation as part of the hazard assessment. The advantages and 490 
disadvantages of these approaches for hazard assessment in groundwater are discussed in the following 491 
sections.  492 
5.2.1 Classification based on the PBT assessment  493 
It has been suggested that the reason persistence has often been disregarded in prioritisation approaches 494 
is that it is less relevant when there is a continuous discharge into rivers. 57,77 However, for groundwaters 495 
persistence is an important factor because more persistent ECs are likely to leach and accumulate in 496 
groundwaters. The widespread detection of atrazine in groundwater today, several decades after it 497 
ceased being used, is an example of the importance of chemical persistence in groundwater.28  The PBT 498 
assessment is considered useful for circumstances where the risks are difficult to quantify44, which 499 
makes it relevant to the groundwater context. The PBT approach is also used in the UK to determine if 500 
substances are defined as hazardous in groundwater under the WFD and GWDD.110 501 
For the assessment of persistence, REACH guidelines87 definitions of the vP and P was used in the EU 502 
WFD prioritisation studies58-60. The USA study57 used a higher threshold of >180 to indicate persistent 503 
chemicals. The BIOWIN programme for organic substances can be used to estimate the 504 
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biodegradability in environmental conditions.59,72 This was used in the EU WFD prioritisation studies58-505 
60  and a Spanish study72. For the assessment of toxicity in the PBT approach the studies generally used 506 
the classification under the REACH guidelines87 or dose-response data, sometimes alongside the risk 507 
ratio approach. 508 
For the assessment of bioaccumulation, European guidance recommends that the bioconcentration 509 
factor (BCF) for aquatic species is used, mostly from fish.59,87 The BCF is the ratio of a substance’s 510 
concentration in an organism and its quantity freely dissolved in ambient water.59 This approach was 511 
used in only three of the studies in this review, with differing thresholds for risk. The logKow is also 512 
used to estimate a contaminants potential to bioaccumulate within an organism.64 Two studies59,64 used 513 
a threshold of a logKow > 4.5 to indicate a risk of bioaccumulation. This threshold originates from EMA 514 
guidelines66,87 which required pharmaceuticals to be screened for further assessment. The USA study57 515 
used a similar threshold of logKow >5, and another study69 used a threshold of 3, to indicate 516 
bioaccumulation potential. One of the studies64 did highlight the weaknesses of using logKow as an 517 
indicator of bioaccumulation for pharmaceuticals as they are mostly polar and ionisable. For ECs such 518 
as pharmaceuticals there has been little research on their bioaccumulation potential in biota.111 519 
5.2.2 Classification based on long-term health effects 520 
Studies that used long-term health effects data for hazard assessment did so to assess the risk to human 521 
health. One study52 scored ECs based on their potential to cause carcinogenic, teratogenic, mutagenic, 522 
endocrine disruption and neurotoxic effects. Its authors suggested that this method is more appropriate 523 
due to chronic exposure and endpoints such as carcinogenicity and endocrine disruption being realistic 524 
hazards. Another advantage of this method is that MECs or PECs are not necessarily required. Another 525 
study69 prioritised the hazard using seven categories for human health effects, which incorporated dose-526 
response ecotoxicology data for PPCPs and endocrine disrupting compounds for human health.  527 
Both of these studies52,69 used intermediate scores when there was no data to ensure that they were 528 
deemed higher risk than an EC classified as having no effect. It was emphasised by one of the studies69, 529 
that an important issue with these prioritisation approaches was lack of data for many of the health 530 
effects categories. For example, 62% of data in the carcinogenicity category and 82% in the fertility 531 
impairment were missing, which resulted in a high uncertainty of results.69 The lack of an official 532 
definition of endocrine disrupting compounds also makes scoring ECs based on this criterion inherently 533 
difficult.60  534 
Weightings used to assign importance to different criteria are subjective.71 It therefore is a complex task 535 
and the easiest option can be to assign equal weightings to all different categories.69,72 For example, one 536 
study69 gave equal weight to health effects categories, whereas others such as, 52,63, weighted the scores 537 
to give more importance to carcinogenicity and mutagenicity. Expert judgement is used to assign 538 
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weightings and can allow decision makers to set priorities; even the importance of different receptors, 539 
i.e. human health or aquatic ecology.69,71  540 
5.3 Outlook for approaches for hazard assessment of ECs in groundwater 541 
The review highlighted that the use of dose-response toxicity data to characterise the hazard of ECs was 542 
the most common approach and only two studies did not use it. However, there is a paucity of toxicity 543 
data for many ECs and data is often not accessible due to protection from ‘commercial-in-confidence’.42  544 
The main concern of ECs in groundwater relates to long-term exposure at relatively low concentrations.  545 
In this context there are some issues with the prioritisation approaches reviewed. In particular the 546 
reliance on acute toxicological data rather than chronic toxicological data could misrepresent the risk. 547 
Only few studies considered chronic exposure endpoints such as carcinogenicity and endocrine 548 
disruption (approximately 28%) but there was a higher portion of the groundwater studies (55%) that 549 
did. There are also significant gaps in this type of toxicological classification data which can create high 550 
uncertainty in the hazard assessment results. 551 
Unlike surface waters the main source of ECs is not through rapid continuous discharges and therefore 552 
the accumulation of ECs is an important consideration. Only two groundwater studies used persistence 553 
or bioaccumulation as part of the hazard assessment. There is no standard approach for the assessment 554 
of bioaccumulation, and for ECs such as pharmaceuticals the evidence in the literature on their 555 
bioaccumulation potential in biota is still limited but is a growing research area.112-114 556 
When using the classification approach based on long-term health effects, weightings are generally used 557 
to assign importance to a criterion. These weightings are subjective and therefore sensitivity testing 558 
should be built into any prioritisation approach to understand the uncertainties and the robustness of the 559 
results.  560 
It is clear that greater accessibility and generation of toxicity data for ECs is required and that there are 561 
many uncertainties in the hazard assessment approaches. Future approaches for assessment of the 562 
hazard of ECs in groundwater should incorporate flexibility to update prioritisation results as new data 563 
becomes available, and research on the most appropriated approaches for groundwater are determined 564 
and refined.  565 
6 Comparison of prioritisation approaches 566 
Two subsets of prioritisation studies (ECs and pharmaceuticals) were analysed, to compare the 567 
chemicals on the prioritised lists to provide an indication of the impact of different approaches on the 568 
results. Only substances that were classified as ECs by the NORMAN network (and not ‘classical’ 569 
contaminants) were included in the analysis. The selection process for studies and substances included 570 
are described in Supplementary Information A.  571 
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The first subset of studies included five studies that prioritised ECs (see Supplementary Information 572 
D). There were 37 ECs included in this analysis. Only three ECs were prioritised in more than one of 573 
the studies: diazinon, triclosan and estrone. Diazinon is a pesticide and is regulated in some countries 574 
so is not typically considered an emerging contaminant.  575 
The second subset of studies included six studies that prioritised human pharmaceuticals (see 576 
Supplementary Information D). There were 64 pharmaceuticals included in this analysis. The studies 577 
had been carried out in several different countries: UK80, two from France73,64, Iraq78, Lebanon81 and 578 
China11. Three pharmaceuticals were prioritised in five of the six studies: carbamazepine, diclofenac 579 
and ibuprofen. Three others were prioritised in four studies: amoxicillin, ciprofloxacin and 580 
clarithromycin. Overall a total of 20 of the 64 pharmaceuticals were prioritised in more than one study 581 
(31%). 582 
The comparison of prioritisation results for the two subsets of studies, has shown that there were more 583 
similarities between the prioritisation studies for pharmaceuticals. This can be attributed to the 584 
similarities between the initial lists of chemicals. The initial lists of pharmaceutical studies were 585 
generated from similar sources such as prescription and usage data but in several different countries. 586 
All the studies used the PEC and dose-response data. One study73 was an exception, its authors used the 587 
MECs and it did have fewer pharmaceuticals in common with the other studies.  588 
Three of the pharmaceutical studies also compared their ranking outcomes to results from other 589 
publications. In the first it was found that carbamazepine and ibuprofen were the most prioritised 590 
pharmaceuticals among the eight studies they examined.81 They also highlighted that six (out of 26) of 591 
their prioritised pharmaceuticals were not prioritised elsewhere.81 The second78 found that amoxicillin, 592 
which they ranked highest, also ranked highly in earlier studies in the UK and Korea (58,64). The third 593 
study11 compared its priority list to a previous review of prioritisation results for pharmaceuticals.114 594 
Nine of the high priority pharmaceuticals had been identified in the previous review.11 The study’s 595 
authors also examined previous prioritisation research in France64 and Switzerland116 and found that 596 
there were similarities to their own list, despite the use of different methodologies.11  597 
The two EC studies that had more than one prioritised EC (triclosan and estrone) in common employed 598 
quite different methodologies. The initial lists of ECs were generated by different means and from 599 
different sources. The studies also had significantly different numbers of substances on their initial lists 600 
ranging from 34 to 2024 ECs (including classical chemicals prior to filtering), and were carried out in 601 
Europe and the USA. It is not surprising that the prioritisation results from EC studies reviewed here 602 
are variable. These studies can include a complex mixture of types of contaminants with different 603 
sources and pathways to the aqueous environment. The substances (Table F of the Supplementary 604 
Information) included pesticides applied to agricultural land that reaches water via runoff or infiltration 605 
through the soil (such as cyanazine or diazinon), pharmaceuticals and industrial fragrances (such as 606 
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galoxalide) which probably enter the environment via wastewater, as well as plasticisers (bisphenol A) 607 
and flame-retardants (perfluorooctanoic acid). 608 
One of the other studies57 in this review applied two hazard assessment approaches for ECs in surface 609 
water: a scoring system that incorporated persistence and bioaccumulation scores (PBT approach); and 610 
the risk ratio. The ECs identified by each approach were markedly different. The risk ratio approach 611 
yielded the lowest number (n = 41) compared with the PBT approach which used the risk ratio for 612 
toxicity (n = 60). Nearly half of the ECs identified by the first approach had relatively low half-lives 613 
(<60 days).  614 
It is apparent that comparing the prioritisation results to determine any commonalities is unsatisfactory 615 
without first analysing the initial lists (which unfortunately have rarely been provided) and assessing 616 
the substance type. Although most studies are therefore not directly comparable, it has been helpful to 617 
provide an indication of the parallels between the priority lists for pharmaceuticals.81 Given the 618 
uncertainties with developing any prioritisation approach,61 it is useful to make an attempt to evaluate 619 
the results through comparison with other similar prioritisation approaches. This has been undertaken 620 
in some studies (e.g. 11,78,81), but there was still a lack of analysis of the initial lists and differences 621 
between prioritisation methodologies. There is also merit in carrying out more than one prioritisation 622 
using different methods, or sensitivity testing results to understand the uncertainty surrounding the 623 
prioritised lists. This would minimise the risk of prioritising ECs that are lower risk or missing ones 624 
that could be higher risk in the groundwater environment e.g. persistent chemicals.  625 
7 Framework for prioritisation approaches and future outlook 626 
This review has demonstrated that a common approach for prioritising ECs in groundwater has not been 627 
developed and verified. Two main issues were revealed by the review.  Firstly, the groundwater 628 
exposure tools and models examined in this study all had merit, however they need to be confirmed 629 
using actual groundwater quality data50, whilst still considering the lag times. The level of detail 630 
required to provide realistic estimates of loading or concentrations in groundwater therefore remains 631 
unknown. For example, soil organic carbon was found to be important for sorption of ECs (e.g. 50,54) 632 
but some of the simpler approaches depend on the physico-chemical properties of the EC which often 633 
do not reflect real environmental conditions.84,90,91 There will always be trade-offs between complexity, 634 
accuracy and data requirements.117 The use of MECs is the preferred method for surface water and 635 
groundwater when adequate data is available. It is a more reliable method for representing 636 
environmental exposure especially for groundwaters where it is difficult to predict concentrations. 637 
Careful consideration is required when summarising MEC data and dealing with results below the LOD 638 
so that the data is representative of the risk of exposure.  639 
Secondly, the review has highlighted the paucity of toxicity data and physico-chemical data for ECs 640 
and issues with access to available data. Due to the risk of ECs accumulating and the potential chronic 641 
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effects, the long-term health effects classification data will be important to incorporate.52,81 However, 642 
there are still significant gaps in chronic dose-response toxicological data and long-term health effects 643 
classification data for ECs.  644 
Lastly this review has indicated that no prioritisation approach is perfect, and it has not demonstrated 645 
that one approach is superior to any other, but has highlighted some important advantages and 646 
disadvantages. There is an indication that the most comprehensive prioritisation approaches are ones 647 
that use a combination of approaches, for example, the risk ratio and scoring methods for hazard 648 
assessment (e.g. 57,81). It has also been shown that the persistence of the EC is important in the 649 
groundwater context with the example of carbamazepine accumulation in soil and leaching to 650 
groundwater.104 The dose-response hazard classification can omit highly persistent ECs57 and the 651 
possibility of bioaccumulation of ECs.  652 
The uncertainties with the results of any prioritisation approach require greater effort in scrutinising the 653 
results, sensitivity test them and comparing them with other similar studies. Further research is required 654 
to analyse the advantages of different prioritisation approaches to optimise the best one for ECs in 655 
groundwater. Prioritisation of ECs should not be a static process and improvements in the approaches 656 
should be sought and incorporated. Future prioritisation approaches should incorporate flexibility to 657 
update prioritisation results as new data becomes available.  658 
Therefore, a broad framework is proposed, that facilitates the incorporation of research on the 659 
occurrence, hazards and prioritisation of ECs and an evaluation process. A phased approach adapted for 660 
groundwater from Maruya et al.75 is proposed as outlined in Figure 3. The figure also highlights the key 661 
priority research areas of: 1) sorption and degradation of ECs in the environment; 2) evaluation of 662 
different exposure characterisation approaches to confirm the level of detail required to provide 663 
estimates of loading or concentrations in groundwater; 3) the chronic toxicity of ECs and health 664 
classification data; 4) comparison of prioritisations approaches for groundwater. For example, the effect 665 
of combining prioritisation approaches such as the risk ratio and scoring approaches could be 666 
researched, as well as the influence of including persistence and bioaccumulation as factors. 667 
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 668 
Figure 3 A phased framework for prioritisation of ECs in groundwater incorporating key 669 
research requirements   670 
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This framework and future research will hopefully enable the prioritisation methodologies to be 671 
improved by feeding back results from the evaluations of the prioritisation approach and allowing the 672 
incorporation of new data. This phased approach could also be verified with existing monitoring data 673 
for ECs in groundwater. 674 
The first phase involves developing the conceptual understanding and approach. The first step is to 675 
define the objectives of the prioritisation approach. This ought to be done by both scientists and policy 676 
makers or decision makers,2 determining the priorities (human health, aquatic ecology or both). In 677 
addition, it would be important to consider the scale of occurrence to be considered. The WFD, for 678 
example, would require that both human health and ecology are considered and the occurrence to be 679 
examined at a groundwater body scale.42,43  680 
The next step would be to develop the initial conceptual model for the source, pathway and receptors 681 
of ECs in groundwater. Given the wide variety of ECs and difference in source types, it is considered 682 
that a pragmatic approach would be to develop scenarios that focus on certain sources and groups of 683 
substances that can then be tested.42,75 Such scenarios for groundwater could be designed around the 684 
current understanding of the sources of ECs (see Figure 117). One exemplary scenario could relate to 685 
the ECs found in wastewater discharges from septic tanks and other private treatments works which 686 
discharge to groundwater. It would also be important to monitor in areas with high and low groundwater 687 
vulnerability to be representative of the risk spectrum43 and allow different groundwater vulnerability 688 
settings to be tested. 689 
The second phase involves the actual prioritisation process. A prioritisation approach that is appropriate 690 
for groundwater and the identified receptors needs to be selected. An initial priority list of ECs to be 691 
monitored can be developed based on the characterisation of environmental exposure and hazard. The 692 
results of the prioritisation of ECs should be sensitivity tested to understand the level of uncertainly 693 
around the data used and any scores or weightings. Carrying out more than one prioritisation approach 694 
using the same initial list and a further analysis of the resulting priority lists would help to ensure that 695 
results are robust and that the decision makers are informed of the uncertainties that require 696 
consideration. 697 
The third phase involves monitoring the prioritised ECs in groundwater and verifying the conceptual 698 
models and exposure characterisation by relating the MECs to the exposure scenario.75 The monitoring 699 
can then be adapted as needed based on the monitoring results and evaluation studies (see Figure 3).75 700 
The lag times between environmental release and occurrence in groundwater needs to be reflected. This 701 
evaluation step can also be used to adapt the prioritisation approach if required and reassess 702 
prioritisation results. Additional feedback loops are proposed to incorporate new physico-chemical data 703 
and hazard classification and toxicity data.  704 
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The framework addresses the problem of the lack of knowledge on occurrence and fate of ECs, and 705 
uncertainties surrounding prioritisation results. The prioritisation process needs to be dynamic and 706 
responsive as new information becomes available, for example, through the proposed voluntary 707 
European GWWL process, refinements can also be made to the conceptual models and subsequent 708 
priority lists. The framework will ultimately enable further groundwater monitoring data to be gathered 709 
for ECs that pose the highest risk to groundwater receptors, while paving the way for an optimised 710 
approach for prioritising ECs in groundwater.  711 
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